Elucidating Drivers for Variations in the Explosive Human Immunodeficiency Virus Epidemic among People Who Inject Drugs in Pakistan

Aaron G Lim*, Adam J W Trickey, Laura Thompson, Faran Emmanuel, Tahira Reza, Rosy A Reynolds, Francois Cholette, Dessalegn Melesse, Chris Archibald, Paul Sandstrom, James F Blanchard, Peter T Vickerman

*Corresponding author for this work

Research output: Contribution to journalArticle (Academic Journal)peer-review

52 Downloads (Pure)

Abstract

Background
Pakistan’s explosive human immunodeficiency virus (HIV) epidemic among people who inject drugs (PWID) varies widely across cities. We evaluated possible drivers for these variations.

Methods
Multivariable regression analyses were undertaken using data from 5 national surveys among PWID (n = 18 467; 2005–2017) to determine risk factors associated with variations in city-level HIV prevalence. A dynamic HIV model was used to estimate the population-attributable fraction (PAF; proportion of HIV infections prevented over 10 years when that risk factor is removed) of these risk factors to HIV transmission and impact on HIV incidence of reducing their prevalence.

Results
Regression analyses suggested that city-level HIV prevalence is strongly associated with the prevalence of using professional injectors at last injection, heroin use in last month, and injecting ≥4 times per day. Through calibrating a model to these associations, we estimate that the 10-year PAFs of using professional injectors, heroin use, and frequent injecting are 45.3% (95% uncertainty interval [UI], 4.3%–79.7%), 45.9% (95% UI, 8.1%–78.4%), and 22.2% (95% UI, 2.0%–58.4%), respectively. Reducing to lowest city-level prevalences of using professional injectors (2.8%; median 89.9% reduction), heroin use (0.9%; median 91.2% reduction), and frequent injecting (0.1%; median 91.8% reduction) in 2020 reduces overall HIV incidence by 52.7% (95% UI, 6.1%–82.0%), 53.0% (95% UI, 11.3%–80.2%), and 28.1% (95% UI, 2.7%–66.6%), respectively, over 10 years.

Conclusions
Interventions should focus on these risk factors to control Pakistan’s explosive HIV epidemic among PWID, including a concomitant expansion of high-coverage needle/syringe provision, opioid substitution therapy, and antiretroviral therapy.
Original languageEnglish
Article numberofab457
Number of pages11
JournalOpen Forum Infectious Diseases
Volume8
Issue number9
DOIs
Publication statusPublished - 2 Sept 2021

Bibliographical note

Funding Information:
This study was supported by the Canadian Institutes of Health Research. PV, AGL, AT, and RR acknowledge support from the National Institute for Health Research Health Protection Research Unit in Behavioural Science and Evaluation at the University of Bristol. PV and AGL also acknowledge funding from National Institute of Allergy and Infectious Diseases and the National Institute on Drug Abuse (grant number R01AI147490).*%blankline%*

Publisher Copyright:
© 2021 The Author(s).

Keywords

  • city-level associations
  • contextual factors
  • high-risk behaviour
  • mathematical model
  • population-attributable fraction
  • professional injectors
  • HIV
  • heroin
  • Pakistan
  • epidemics
  • HIV infections
  • HIV transmission

Fingerprint

Dive into the research topics of 'Elucidating Drivers for Variations in the Explosive Human Immunodeficiency Virus Epidemic among People Who Inject Drugs in Pakistan'. Together they form a unique fingerprint.

Cite this